60 Degrees Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises
Reuters
Jul 19
<a href="https://laohu8.com/S/SXTPW">60 Degrees</a> Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises
60 Degrees Pharmaceuticals Inc., a company focused on developing new medicines for infectious diseases, has announced the pricing of a public offering involving 2,631,578 shares of its common stock. This offering includes accompanying Series A-1 warrants and short-term Series A-2 warrants to purchase an equal number of shares, priced at $1.90 per share of common stock. The company anticipates gross proceeds of approximately $5 million from the offering, with the possibility of an additional $5 million if the short-term Series A-2 warrants are fully exercised on a cash basis. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. The proceeds are intended for working capital and general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-065718), on July 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.